A Double-blind, Randomized, Parallel Design Two Center Study to Compare the Effect of Vorapaxar vs. Placebo on Lower Extremity Vein Graft Maturation, Remodeling, and Function

Trial Profile

A Double-blind, Randomized, Parallel Design Two Center Study to Compare the Effect of Vorapaxar vs. Placebo on Lower Extremity Vein Graft Maturation, Remodeling, and Function

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 29 Jan 2018

At a glance

  • Drugs Vorapaxar (Primary)
  • Indications Peripheral arterial disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 23 Jan 2018 Status changed from not yet recruiting to withdrawn prior to enrolment as could not secure adequate medication
    • 13 Sep 2017 Planned initiation date changed from 1 Aug 2017 to 1 Oct 2017.
    • 08 Aug 2017 Planned initiation date changed from 1 Dec 2016 to 1 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top